WIDE study

Wilson’s Disease: epidemiology and treatment in the Netherlands. - WIDE study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57680

Enrollment

230

Registered

2025-02-03

Start date

2025-06-19

Completion date

Unknown

Last updated

2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson's disease, hepatolenticular degeneration, copper disorder, copper storage disease Copper accumulation disease

Interventions

Niet van toepassing

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Wilson's disease or highly suspicion of Wilson's disease according to Leipzig criteria (greater or equal to 3)Patients must have given written informed consent. According to Dutch law, caregivers have to give (additional) written informed consent for children < 16 years.

Exclusion criteria

Exclusion criteria: No informed consent

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: The primary endpoints of this study are the identification of WD patients in the Netherlands; Patient characteristics including clinical condition, severity of liver disease and severity of neurological/psychiatric disease.; treatment and efficacy of decoppering in Dutch WD patients.	—

Secondary

Measure	Time frame
Secondary endpoints: treatment adherence, QoL, incidence of adverse outcomes.	—

Countries

Netherlands

Contacts

Public ContactC.M. Hoed

Erasmus MC, Universitair Medisch Centrum Rotterdam

c.denhoed@erasmusmc.nl0107035942

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 25, 2026